>>11615988>I am wondering about is how such things happenThe Gates foundation provides funds mostly to start-up organization with promising out-of-the-box ideas rather than established research centers. As such, it has potential to produce innovative solutions but very few of its funded projects are likely to succeed.
Besides that all, let's not forget that:
1) the total endowment of the Gates foundation is about 46 billion, but only a small fraction of that goes towards a SARS-cov2 vaccine.
2) Oxford isn't exactly strapped for cash, especially at the moment
3) The majority of cost for vaccines lie in their mass production rather than the R&D that precedes it, and the former will more than likely be carried by the respective governments rather than scientific organizations and their investors / funding agencies
4) no one has actually succeeded yet, clinical trials are still ongoing
